Superiority of anthracycline‐free treatment in standard‐risk acute promyelocytic leukemia: A systematic review and comparative epidemiological analysis

Superiority of anthracycline‐free treatment in standard‐risk acute promyelocytic leukemia: A systematic review and comparative epidemiological analysis

Abstract Background Recent advances in the treatment of acute promyelocytic leukemia (APML) have seen unprecedented improvements in patient outcomes. However, such rapid growth in understanding often leads to uncertainty regarding superiority among candidate treatment regimens, especially when furth...

Full description

Bibliographic Details
Main Authors:	Kane Langdon, Stevie Cosentino, Olivia Wawryk
Format:	Article
Language:	English
Published:	Wiley 2024-03-01
Series:	Cancer Reports
Subjects:	acute promyelocytic leukemia all‐trans retinoic acid arsenic trioxide chemotherapy epidemiology
Online Access:	https://doi.org/10.1002/cnr2.2035

Similar Items

Acute Promyelocytic Leukemia: Simplifying Treatment in a Resource Poor Setting
by: Rohan Bhise, et al.
Published: (2021-10-01)

Acute Promyelocytic Leukemia during Pregnancy: A Systematic Review of the Literature
by: Andrea Santolaria, et al.
Published: (2020-04-01)

Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy
by: Carmelo Gurnari, et al.
Published: (2021-01-01)

Blood Parameters in Treatment with Arsenic Trioxide in Acute Promyelocytic Leukemia: A Systematic Review
by: Mehdi Mohammadi Kanesbi, et al.
Published: (2020-04-01)

Acute Promyelocytic Leukemia: A History over 60 Years—From the Most Malignant to the most Curable Form of Acute Leukemia
by: Xavier Thomas
Published: (2019-02-01)

CD71-mediated liposomal arsenic-nickel complex combined with all-trans retinoic acid for the efficacy of acute promyelocytic leukemia
by: Xiao Liu, et al.
Published: (2023-07-01)

The Coagulopathy of Acute Promyelocytic Leukemia: An Updated Review of Pathophysiology, Risk Stratification, and Clinical Management
by: Jack Hermsen, et al.
Published: (2023-07-01)

Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale
by: Riccardo Masetti, et al.
Published: (2023-04-01)

Leucemia promielocítica de reciente diagnóstico. Tratamiento con trióxido de arsénico de producción nacional (Arsenin®)
by: Carlos Hernández Padrón, et al.

Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial
by: Xinxin Zhang, et al.
Published: (2018-09-01)

Acute Promyelocytic Leukemia: Review of Complications Related to All-Trans Retinoic Acid and Arsenic Trioxide Therapy
by: Alexandra Ghiaur, et al.
Published: (2024-03-01)

History of Acute Promyelocytic Leukemia
by: Miguel A. Sanz, et al.
Published: (2021-07-01)

The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome
by: Dominic LaBella, et al.
Published: (2022-08-01)

Acute promyelocytic leukemia: An experience on 95 Greek patients treated in the all-trans-retinoic acid era
by: Maria Pagoni
Published: (2014-08-01)

Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial
by: Li Zhang, et al.
Published: (2018-04-01)

ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.
by: Damla Ortaboz, et al.
Published: (2023-03-01)

Trióxido de arsénico: una nueva luz en el tratamiento de la leucemia promielocítica Arsenic trioxide: a new light in the treatment of promyelocytic leukemia
by: Carlos Hernández Padrón, et al.
Published: (2008-08-01)

First report of acute promyelocytic leukemia in a patient with Wilson’s disease: contemporary discussion of a management challenge
by: Zainab AlDawood, et al.
Published: (2023-12-01)

Differentiation Syndrome with Severe Abdominal Pain During Induction Treatment of Acute Promyelocytic Leukemia: A Case Report
by: Yan H, et al.
Published: (2021-06-01)

History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies
by: Pierre Bercier, et al.
Published: (2024-03-01)

Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial
by: Xinxin Zhang, et al.
Published: (2020-01-01)

Case Report: Co-existence of a novel EXOC4‐TRHDE gene fusion with PML-RARA in acute promyelocytic leukemia
by: Xiaodong Liu, et al.
Published: (2023-04-01)

A short report of novel RARG-HNRNPM fusion gene in resembling acute promyelocytic leukemia
by: Yang Song, et al.
Published: (2022-12-01)

Treatment for acute promyelocytic leukemia during pregnancy
by: V V Troitskaia, et al.
Published: (2013-10-01)

Acute promyelocytic leukemia. State of the art
by: Leonardo Mejía-Buriticá, et al.
Published: (2021-01-01)

A case of acute promyelocytic leukemia with morphologic multilineage dysplastic changes
by: Setsuki Isono, et al.
Published: (2013-02-01)

Treatment of adult patients with acute promyelocytic leukemia according to the AIDA protocol
by: E N Parovichnikova, et al.
Published: (2013-07-01)

The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions
by: Sunil Girish Iyer, et al.
Published: (2023-01-01)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
by: Peng Zhang
Published: (2017-01-01)

Editorial: Acute Promyelocytic Leukemia — Towards A Chemotherapy-Free Approach to Cure in All Patients
by: Harinder Gill, et al.
Published: (2022-01-01)

Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia
by: Jaime Sanz, et al.
Published: (2021-03-01)

Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis
by: Jose Tinajero, et al.
Published: (2022-01-01)

Late differentiation syndrome in acute promyelocytic leukemia: a challenging diagnosis
by: Renata Cabral, et al.
Published: (2014-11-01)

Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy
by: Giorgio Rosati, et al.
Published: (2023-07-01)

Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2
by: Károly Jambrovics, et al.
Published: (2020-03-01)

Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments
by: Bülent Özpolat
Published: (2009-06-01)

Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia
by: Uday Kulkarni, et al.
Published: (2021-02-01)

Thrombocytosis in a patient with acute promyelocytic leukemia during treatment with all‐trans retinoic acid and arsenic trioxide
by: Maryam Habibi, et al.
Published: (2021-04-01)

Scrotal ulceration following all-trans retinoic acid therapy for acute promyelocytic leukemia
by: Illias Tazi, et al.
Published: (2011-01-01)

ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report
by: Laura Pardo Gambarte, et al.
Published: (2022-04-01)